IQE PLC

Director's Dealing • Dec 1, 2025

National Storage Mechanism | Additional information

RNS Number : 7235J

IQE PLC

01 December 2025

IQE plc

Cardiff, UK

1 December 2025

Issue of Options Director/PDMR Shareholding

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, advises that on 1 December 2025, Mark Cubitt, Executive Chair received a grant of nil cost share options ("Options") over ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to IQE's Long Term Incentive Plan ("LTIP").

Mark Cubitt has received immediately vested Options over 166,667 Ordinary Shares under the LTIP. Further to the grants made on 8 June 2025 and 1 September 2025, it is intended that Mark will be granted an Option over a further 166,666 Ordinary Shares at the start of the next subsequent calendar quarter in March 2026, provided that he has not returned to his non-executive chair role prior to that date. The total number of Options granted to Mark will therefore be 666,667. Mark's Options and resulting Ordinary Shares are subject to a three-year holding period from the date of grant.

Contacts:

IQE plc

+44 (0) 29 2083 9400

Mark Cubitt

Jutta Meier

Amy Barlow

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Ben Cryer

Kate Bannatyne

Adam Telling

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

Headland Consultancy (Financial PR)

+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")
a)	Name	Mr Mark Cubitt
2.	Reason for the notification
a)	Position / status	PDMR (Executive Chair)
b)	Initial notification / amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IQE plc
b)	Legal Entity Identifier	213800Y33WHD3ESJJP16
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary shares of 1 pence each in the Company GB0009619924
b)	Nature of the transaction	Award of options
c)	Price(s) and volume(s)	166,667 Ordinary Shares
d)	Aggregated information ·       Aggregated volume ·       Aggregated price
e)	Date of the transaction(s)	1 December 2025
f)	Place of the transaction	Off-market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPKDBDNBDDKBK